A systematic review of more than two decades of clinical [...]

ViiV Healthcare has received US FDA approval for Tivicay PD [...]

AstraZeneca and Amgen’s Tezspire has met both co-primary and key [...]

The US FDA has approved Revolution Medicines’ daraxonrasib for adults [...]

Biogen’s felzartamab has been approved in China as a treatment [...]

Agenus has reported deep tumour responses and no observed colorectal [...]

CEPI will provide up to $16.5 million to Minapharm to [...]

Sagimet Biosciences is preparing to begin screening patients for its [...]

The FDA has approved ViiV Healthcare’s Tivicay PD for children [...]

Saama’s Chief Customer Success and Growth Officer Ari Srinivasan speaks [...]